V118 Formulation C

V118C · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V118 Formulation C, covering 2026-01-20 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001) [Phase 1]